ELIZABATH GEORGE: Open Payments
NPI 1972067379 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 55 payments from 9 companies in 2025. Trend: 2023 $865 · 2024 $1,053 · 2025 $1,422
Food & beverage: $1,310Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 29 | $635 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $239 |
| Janssen Pharmaceuticals, Inc | 2 | $158 |
| Neurocrine BioSciences, Inc. | 3 | $138 |
| E.R. Squibb & Sons, L.L.C. | 6 | $117 |
| Alkermes, Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: UZEDY, CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, INGREZZA, COBENFY, ARISTADA, Auvelity.
Industry payments across TX — which companies pay providers there.
